<DOC>
	<DOC>NCT02675335</DOC>
	<brief_summary>The purpose of the study is to test the effect of Sitagliptin on the healing of stable, nonhealing diabetic foot ulcers. This is a randomized placebo-controlled Trial.</brief_summary>
	<brief_title>Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>type 2 diabetes mellitus at least 1 diabetic foot ulcer with a size between 1 and 20 sqcm stable size of the foot ulcer for at least 2 weeks HbA1c &lt;= 8% under Treatment with Insulin, metformin, sulfonylureas, SGLT2 Inhibitors, glinides or glitazones local purulent signs of Inflammation at ulcer site planned interventional or surgical therapy of a macro vessel disease of the lower limb glomerular filtration rate &lt;30ml/min liver cirrhosis CHILD B or C pregnancy, lactation allergy against Sitagliptin ongoing treatment with dipeptidyl peptidase 4 (DPP4) Inhibitors</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Diabetic foot ulcer, Sitagliptin</keyword>
</DOC>